Although serum ALT levels are often used as a surrogate marker for liver inflammation, ALT is typically elevated in only 50% of non-alcoholic fatty liver disease (NAFLD) cases [20, 28]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.